Positive results from the global COAST 1 phase 3 study (clinical study identifier: NCT06130566) showed that amlitelimab, a fully human non-T cell depleting monoclonal antibody that targets OX40-ligand ...
Regeneron has reported a phase 3 win in generalized myasthenia gravis (gMG), positioning the pharma to file for FDA approval of its siRNA candidate in the increasingly competitive neuromuscular ...
WASHINGTON – Taking the stage after his landslide victory in South Carolina, Joe Biden hugged his longtime friend Rep. James Clyburn, who gave the former vice president a coveted endorsement three ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
An easy-to-use bridge that lets AI assistants like Claude directly query and explore Microsoft SQL Server databases. No coding experience required! DB_USER=your ...
Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every four weeks or every 12 weeks, ...
Total Sales Analysis: Evaluates overall revenue generated by the coffee shop. Total Orders Analysis: Tracks the number of orders placed over time. Total Quantity Sold: Monitors the quantity of items ...
see more of our stories on Google. Add Axios on Google Rep. Jerry Nadler sits with his delegation during the Democratic National Convention in Chicago, Ill., on Aug. 20, 2024. Photo: Andrew ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback